P60 A retrospective evaluation of the effectiveness and safety of palliative long-term abdominal drains for the management of refractory ascites in patients with end stage liver disease, in comparison with large volume paracentesis

Abstract

IntroductionPatients with end-stage liver disease (ESLD) and refractory ascites (RA) have a median transplant-free survival of 6 months. Large volume paracentesis (LVP) is the first-line treatment recommended by the current...